cyproterone acetate

Preferred Label : cyproterone acetate;

MeSH definition : An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites.;

Wikipedia automatic translation : Cyproterone;

MeSH hyponym : cyproterone acetate, (1 alpha,2 alpha)-Isomer; cyproterone acetate, (17 alpha)-Isomer; cyproterone acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer; androcur;

MeSH CAS label : 3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 17-(acetyloxy)-6-chloro-1,2-dihydro-, (1beta,2beta)-;

MeSH Related Number : cyproterone acetate, (17 alpha)-Isomer; cyproterone acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer; cyproterone acetate, (1 alpha,2 alpha)-Isomer; 34542-28-4 ((1 alpha,2 alpha,9 beta,10 alpha)-isomer); 427-51-0 (Cyproterone acetate); 52437-31-7 (cpd w/o isomeric designation); 57-38-5 ((1 alpha,2 alpha)-isomer); 86782-20-9 ((17 alpha)-isomer);

Registry Number MeSH : 427-51-0;

Related CAS MeSH : 86782-20-9 (Cyproterone acetate, (17 alpha)-Isomer); 34542-28-4 (Cyproterone acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer); 57-38-5 (Cyproterone acetate, (1 alpha,2 alpha)-Isomer);

Wikipedia link : https://en.wikipedia.org/wiki/Cyproterone;

Is substance : O;

UNII : 4KM2BN5JHF;

InChIKey : UWFYSQMTEOIJJG-FDTZYFLXSA-N;

Details

Origin ID

D017373;

UMLS CUI

C0056855;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Cyproterone acetate (substance) [SNOMED CT concept]
- cyproterone acetate [Substance BNPC]
Exact mapping(s) to DCI
- cyproterone acetate [International Nonproprietary Name]
Pharmacological action(s)
- androgen antagonists [MeSH Descriptor]
- antineoplastic agents [MeSH Descriptor]
- contraceptive agents, male [MeSH Descriptor]
Record concept(s)
- androcur [MeSH concept]
- cyproterone acetate [MeSH concept]
- cyproterone acetate, (1 alpha,2 alpha)-Isomer [MeSH concept]
- cyproterone acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer [MeSH concept]
- cyproterone acetate, (17 alpha)-Isomer [MeSH concept]
Related MeSH Supplementary Concept(s)
- 15-hydroxycyproterone acetate [MeSH Supplementary Concept]
- 17-hydroxycyproterone acetate [MeSH Supplementary Concept]
- 3 alpha-hydroxy-cyproterone acetate [MeSH Supplementary Concept]
- cyproterone acetate, ethinyl estradiol drug combination [MeSH Supplementary Concept]
- estradiol valerate, cyproterone acetate drug combination [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cyproterone Acetate [NCIt concept]
- Cyproterone acetate (substance) [SNOMED CT concept]
- cyproterone acetate [Substance BNPC]
- cyproterone acetate [International Nonproprietary Name]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients